These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of gastric bypass followed by a randomized study of physical training on markers of coagulation activation, fibrin clot properties, and fibrinolysis. Stolberg CR; Mundbjerg LH; Funch-Jensen P; Gram B; Juhl CB; Bladbjerg EM Surg Obes Relat Dis; 2018 Jul; 14(7):918-926. PubMed ID: 29706497 [TBL] [Abstract][Full Text] [Related]
4. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis. Konieczynska M; Fil K; Bazanek M; Undas A Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139 [TBL] [Abstract][Full Text] [Related]
5. Altered fibrin clot properties and fibrinolysis in patients with atrial fibrillation: practical implications. Undas A Europace; 2020 Feb; 22(2):185-194. PubMed ID: 31625555 [TBL] [Abstract][Full Text] [Related]
6. The clot lysis time-based assay and the variability associated with interpretation of data. Montalvão SAL; de Moraes Martinelli B; da Silva Souza Gois G; Huber SC; De Paula EV; Annichino-Bizzacchi JM Int J Lab Hematol; 2023 Apr; 45(2):e43-e46. PubMed ID: 36372983 [No Abstract] [Full Text] [Related]
7. Fibrinolysis and the control of blood coagulation. Chapin JC; Hajjar KA Blood Rev; 2015 Jan; 29(1):17-24. PubMed ID: 25294122 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study. Szczepaniak P; Zabczyk M; Undas A PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989 [TBL] [Abstract][Full Text] [Related]
9. Temporal changes in clot lysis and clot stability following tranexamic acid in cardiac surgery. Tang M; Wierup P; Rea CJ; Ingerslev J; Hjortdal VE; Sørensen B Blood Coagul Fibrinolysis; 2017 Jun; 28(4):295-302. PubMed ID: 27607599 [TBL] [Abstract][Full Text] [Related]
10. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis. Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232 [TBL] [Abstract][Full Text] [Related]
11. Reduced plasma fibrin clot permeability and susceptibility to lysis are associated with increased risk of postthrombotic syndrome. Siudut J; Grela M; Wypasek E; Plens K; Undas A J Thromb Haemost; 2016 Apr; 14(4):784-93. PubMed ID: 26786481 [TBL] [Abstract][Full Text] [Related]
12. The impact of the endothelial protein C receptor on thrombin generation and clot lysis. Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843 [TBL] [Abstract][Full Text] [Related]
13. A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders. Nogami K; Matsumoto T; Sasai K; Ogiwara K; Arai N; Shima M Br J Haematol; 2019 Nov; 187(4):518-529. PubMed ID: 31335970 [TBL] [Abstract][Full Text] [Related]
14. Effect of remote ischaemic conditioning on coagulation and fibrinolysis. Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926 [TBL] [Abstract][Full Text] [Related]
15. Uremic toxins alter coagulation and fibrinolysis-related genes expression in human endothelial cells. Oe Y; Sato E; Sato H; Miyazaki M; Ito S; Takahashi N Thromb Res; 2020 Feb; 186():75-77. PubMed ID: 31901643 [No Abstract] [Full Text] [Related]
16. Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients. Wójcik M; Zaręba L; Undas A Thromb Res; 2019 Oct; 182():141-149. PubMed ID: 31479942 [TBL] [Abstract][Full Text] [Related]
17. Global assays of fibrinolysis. Ilich A; Bokarev I; Key NS Int J Lab Hematol; 2017 Oct; 39(5):441-447. PubMed ID: 28497494 [TBL] [Abstract][Full Text] [Related]
18. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor. Morishima Y; Honda Y J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711 [TBL] [Abstract][Full Text] [Related]
19. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood. Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970 [TBL] [Abstract][Full Text] [Related]
20. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots. Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]